Search Results

Avoid wasted resources:  Stop relying on “n=3” by default. Be part of the nonprofit mission to unite the GPCR community.

N., Castro, M., Wang, B., Bouley, R., Potts, J. T., Gardella, T. J., & Vilardaga, J. P. (2009). Reguero, L., Arrabal, S., Elezgarai, I., Gerrikagoitia, I., Suarez, J., Rodríguez De Fonseca, F., Puente, N.

Oncology and Immunology Stable Binding of Full-Length Chemerin is Driven by Negative Charges in the CMKLR1 N-terminus

K., Hoppe, N., Huang, X. P., Macdonald, C. B., Mehrota, E., Grimes, P.

Okashah, N., et al., Agonist-induced formation of unproductive receptor-G(12) complexes. 

Receptor-Associated G Proteins in Two Lepidopteran Species GPCRs in Neuroscience Role of the GRK2/3 N-terminus

This dimerization allows the N-terminal activation domain of the receptor to repeatedly engage and disengage

Differential Responses of the GLP-1 and GLP-2 Receptors to N-Terminal Modification of a Dual Agonist.

First metabolic profiling of 4-n-nonylphenol in human liver microsomes by integrated approaches to testing

assay shows a high signal level with DELTAFA+-SD between total and non-specific points of 0.12+-0.02 (n= displayed. pKi values are calculated as described in Veiksina et al., 2014 , and presented as mean ± SD of n The scale bar corresponds to 10 μm. 2176–2185. https://doi.org/10.1074/jbc.M410385200 . (11)      Mondal, S.; Khelashvili, G.; Johner, N.

Data represent the mean ± SEM (n = 3 in triplicate).

across species with an engineered sensor A Multi-Angle Approach to Predict Peptide-GPCR Complexes: The N/

Lu, N., & Malemud, C. J. (2019).

M., Tomašević, N., ... & Carreira, E. M. (2024).

cancer growth and invasiveness through regulation of ECM properties and Notch ligand DLL4 Chemokine N-terminal-derived

structure similarity search and models of physiological ligand complexes Luis P Taracena Herrera , Søren N

K., Hoppe, N., Huang, X.-P., Macdonald, C. B., Mehrotra, E., Patrick Rockefeller Grimes, Zahm, A.

suppresses the TGF-α-induced migration of hepatocellular carcinoma cells via inhibition of the c-Jun N-terminal

Adhesion GPCRs GPR56 C-terminal fragment mediates signal received by N-terminal fragment of another adhesion

prostaglandin EP4 receptor GPCR Binders, Drugs, and more Molecular glues as potential GPCR therapeutics N-acyl

Human Amylin 1 Receptor in Complex with CGRP and Gs Protein Industry News Monash University retains its N°

With insights from molecular dynamics, biased signaling, and allosteric modulation, this session lays bare

N., Angelini, A., Waghray, D., Dror, R. O., Ploegh, H. L., & Garcia, K. C. (2015).

Reeves KC, Shah N, Muñoz B, Atwood BK.

Broichhagen Design of allosteric modulators that change GPCR G protein subtype selectivity   Madelyn N

Tracking N- and C-termini of C. elegans polycystin-1 reveals their distinct targeting requirements and

activation mechanism of the class C GPCR dimer mGlu5 Altered O-glycosylation of β1-adrenergic receptor N-terminal

AV1 and AV18A showing specific displacement of CELT331 (80 nM) with fitted IC₅₀ values (mean ± SEM, n

GPCRs in Oncology and Immunology LP2, a cyclic angiotensin-(1-7) analog extended with an N-terminal D-lysine ‘renewed interest’ Addex Strategic Partner Completes Enrollment In Adx71149 Epilepsy Phase 2 Study Part

OR10J5 has been proposed to be a metabolic regulator of cardiac function (Jovancevic N. et.